Skip to content Skip to footer
team-reebye

M.D.

Prof. Rajiv Reebye

Prof. Rajiv Reebye is a Physical Medicine and Rehabilitation (PMR) specialist and Clinical Professor in the department of Medicine at the University of British Columbia (UBC), Vancouver, Canada.

Canada

Biography

Prof. Rajiv Reebye is a Physical Medicine and Rehabilitation (PMR) specialist and Clinical Professor in the department of Medicine at the University of British Columbia (UBC), Vancouver, Canada.

Prof. Reebye is a Fellow of the Royal College of Physicians of Canada (FRCPC).

He is an attending physician on the neuro-musculoskeletal program and on the acquired brain injury programs at GF Strong Rehabilitation Center, Vancouver, Canada.

He is also a consulting physician in the spinal cord clinic at BC Children’s Hospital and at the UBC Multiple Sclerosis Clinic.

Prof. Reebye is the director of the New Westminster Rehabilitation Medicine spasticity clinic- a community based spasticity clinic focusing on the treatment of patients with adult spasticity and also children with spasticity transitioning to adulthood.

He is also co-founder of the Canadian advances in neuro-orthopedics for spasticity congress (CANOSC), an organization created to provide excellence in enhancing collaborative care between physicians and surgeons for the treatment of spasticity.

His research interests include adjunctive therapy post botulinum toxin injections for post stroke spasticity and use of ultrasound for chemodenervation in the treatment of spasticity.

Prof. Reebye teaches locally and internationally on the use of ultrasound guided injections for spasticity management and is a teaching faculty member of the Toxin Academy based at the University of Fribourg, Switzerland.

Prof. Reebye was awarded the Patricia Clugston Award for Excellence in teaching and the Duncan Murray excellence in teaching award from the UBC division of PMR.

Supported by Merz Therapeutics GmbH

Liability for links
Our site contains links to external websites, over which we have no control. Therefore we cannot accept any responsibility for this external content. The respective provider or operator is always responsible for the contents of any linked site. At the time of linking the linked sites where checked for possible legal violations. At the time of linking illegal contents were not indicated. A permanent control of the linked pages is unreasonable without concrete evidence of violation. Upon notification of violations, we will remove such links immediately.

Award scoring criteria

The following criteria will be judged out of a score of 5; (1 is suboptimal; 2 is adequate; 3 is good; 4 is very good; 5 is excellent)

GENERAL

  • Days per week working in spasticity management
  • Average number of spasticity patients managed per month
  • Environment and clinical team (type of institution, location, size/structure of clinical team, particular patient needs)
  • Role of responsibility in managing patients with spasticity
  • Scientific appointments in spasticity
  • Honours for work undertaken in spasticity

SCHOLARLY

  • Number of research projects investigating relevant aspects of spasticity management
  • Impact of research projects investigating relevant aspects of spasticity management
  • Number of peer-reviewed publications on topic
    Number of presentations of research at international meetings
  • Number of presentations at national conferences
  • Teaching/mentorship of younger injectors
  • h-index

CLINICAL

  • Evidence of development or growth of a spasticity program at the applicant’s practice or institution
  • Breadth of services provided, including medications, toxins, physical interventions, and Intrathecal Baclofen Therapy (ITB)
  • Role of responsibility in managing patients with spasticity

ENDORSEMENT

  • Endorsed by senior peer

In the event of a tie, based on the above scoring criteria, the Toxnet Co-Chairs will make the final decision.